Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevalence of low-penetrant germline TP53 D49H mutation in Japanese cancer patients.
Yamaguchi K, Urakami K, Nagashima T, Shimoda Y, Ohnami S, Ohnami S, Ohshima K, Mochizuki T, Hatakeyama K, Serizawa M, Akiyama Y, Maruyama K, Katagiri H, Ishida Y, Takahashi K, Nishimura S, Terashima M, Kawamura T, Kinugasa Y, Yamakawa Y, Onitsuka T, Ohde Y, Sugino T, Ito I, Matsubayashi H, Horiuchi Y, Mizuguchi M, Yamazaki M, Inoue K, Wakamatsu K, Sugiyama M, Uesaka K, Kusuhara M. Yamaguchi K, et al. Among authors: ishida y. Biomed Res. 2016;37(4):259-64. doi: 10.2220/biomedres.37.259. Biomed Res. 2016. PMID: 27545002 Free article.
ProGRP is a possible tumor marker for patients with Ewing sarcoma.
Yamaguchi K, Katagiri H, Takahashi M, Ishida Y, Ono A, Takahashi T, Ohshima K, Mochizuki T, Urakami K, Muramatsu K, Kameya T, Ito I, Nakajima T. Yamaguchi K, et al. Among authors: ishida y. Biomed Res. 2015;36(4):273-7. doi: 10.2220/biomedres.36.273. Biomed Res. 2015. PMID: 26299486 Free article.
Pro-gastrin-releasing peptide as a marker for the Ewing sarcoma family of tumors.
Honda Y, Katagiri H, Takahashi M, Murata H, Wasa J, Hosaka S, Ishida Y, Ito I, Muramatsu K, Mochizuki T, Matsuyama Y, Yamaguchi K. Honda Y, et al. Among authors: ishida y. Int J Clin Oncol. 2019 Nov;24(11):1468-1478. doi: 10.1007/s10147-019-01492-0. Epub 2019 Jul 1. Int J Clin Oncol. 2019. PMID: 31264078
Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients.
Nagashima T, Yamaguchi K, Urakami K, Shimoda Y, Ohnami S, Ohshima K, Tanabe T, Naruoka A, Kamada F, Serizawa M, Hatakeyama K, Matsumura K, Ohnami S, Maruyama K, Mochizuki T, Kusuhara M, Shiomi A, Ohde Y, Terashima M, Uesaka K, Onitsuka T, Nishimura S, Hirashima Y, Hayashi N, Kiyohara Y, Tsubosa Y, Katagiri H, Niwakawa M, Takahashi K, Kashiwagi H, Nakagawa M, Ishida Y, Sugino T, Takahashi M, Akiyama Y. Nagashima T, et al. Among authors: ishida y. Cancer Sci. 2020 Feb;111(2):687-699. doi: 10.1111/cas.14290. Epub 2020 Jan 22. Cancer Sci. 2020. PMID: 31863614 Free PMC article.
Identification of tumor microenvironment-associated immunological genes as potent prognostic markers in the cancer genome analysis project HOPE.
Kondou R, Akiyama Y, Iizuka A, Miyata H, Maeda C, Kanematsu A, Watanabe K, Ashizawa T, Nagashima T, Urakami K, Shimoda Y, Ohshima K, Shiomi A, Ohde Y, Terashima M, Uesaka K, Onitsuka T, Nishimura S, Hirashima Y, Hayashi N, Kiyohara Y, Tsubosa Y, Katagiri H, Niwakawa M, Takahashi K, Kashiwagi H, Nakagawa M, Ishida Y, Sugino T, Notsu A, Mori K, Takahashi M, Kenmotsu H, Yamaguchi K. Kondou R, et al. Among authors: ishida y. Mol Clin Oncol. 2021 Nov;15(5):232. doi: 10.3892/mco.2021.2395. Epub 2021 Sep 13. Mol Clin Oncol. 2021. PMID: 34631056 Free PMC article.
Young Adult Secondary Cancer After Proton Beam Therapy: A Case Study.
Yamamori A, Murayama S, Takahashi I, Akaihata M, Kakuda Y, Sugino T, Aramaki T, Onoe T, Takahashi Y, Ishida Y. Yamamori A, et al. Among authors: ishida y. Adv Radiat Oncol. 2023 Jul 1;9(1):101307. doi: 10.1016/j.adro.2023.101307. eCollection 2024 Jan. Adv Radiat Oncol. 2023. PMID: 38260212 Free PMC article. No abstract available.
Evaluation of whole genome sequencing utility in identifying driver alterations in cancer genome.
Nagashima T, Yamaguchi K, Urakami K, Shimoda Y, Ohnami S, Ohshima K, Tanabe T, Naruoka A, Kamada F, Serizawa M, Hatakeyama K, Ohnami S, Maruyama K, Mochizuki T, Mizuguchi M, Shiomi A, Ohde Y, Bando E, Sugiura T, Mukaigawa T, Nishimura S, Hirashima Y, Mitsuya K, Yoshikawa S, Kiyohara Y, Tsubosa Y, Katagiri H, Niwakawa M, Takahashi K, Kashiwagi H, Yasunaga Y, Ishida Y, Sugino T, Kenmotsu H, Terashima M, Takahashi M, Uesaka K, Akiyama Y. Nagashima T, et al. Among authors: ishida y. Sci Rep. 2024 Oct 12;14(1):23898. doi: 10.1038/s41598-024-74272-0. Sci Rep. 2024. PMID: 39396060 Free PMC article.
3,139 results